Business
SEC Charges Cassava Sciences, Two Former Executives for Misleading Claims About Alzheimer’s Clinical Trial - SEC.gov
By: Sec.gov
- Sep 28 2024
- 0
- 0 Views
Washington D.C., Sept. 26, 2024 The Securities and Exchange Commission today announced Cassava Sciences, Inc., its founder and former CEO, Remi Barbier, and its former Senior Vice President of Neuros… [+4140 chars]
